March 9, 2021 : Issue #1113

TOP STORIES — Diabetes News and Research

Using Albuminuria To Predict CV and Renal Outcomes For T2D

The Bright Side Of Having Diabetes During COVID-19

Effects of Tirzepatide on Patients with Type 2 Diabetes Metabolic Profile

MOST POPULAR ARTICLES OF THE MONTH

#1 Brain Damage Associated with High Blood Glucose

#2 Is It Possible to Train Low-Carb and Compete High-Carb?

#3 Intermittent vs. Continuous Energy Restriction for Weight Loss and Metabolic Improvement

There is no doubt that the Coronavirus has had a gigantic effect on our lives over the past 13 months and will likely continue to for some time. However, some of the precautions we have taken because of the pandemic have had a positive effect on other health issues.

Flu cases are at an all time low, and even asthma symptoms have shown a decrease. These changes are associated with the use of masks and patients paying more attention to their health.

This even extends to diabetes. This week our LECOM intern, Laura Martinez López, has a very interesting feature on how COVID-19 worries have had a positive impact on some patients’ diabetes care.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief

The association between 1-year changes in albuminuria and subsequent risk of cardiovascular and renal events. 

Behavioral changes during the pandemic can improve blood glucose control.

Tirzepatide is both a GIP and GLP-1 receptor agonist.